BlackRock Inc. - KIORA PHARMACEUTICALS INC ownership

KIORA PHARMACEUTICALS INC's ticker is and the CUSIP is 49721T309. A total of 10 filers reported holding KIORA PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BlackRock Inc. ownership history of KIORA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$8,211
-11.7%
14,4620.0%0.00%
Q2 2023$9,298
-80.8%
14,4620.0%0.00%
Q1 2023$48,303
-2.6%
14,4620.0%0.00%
Q4 2022$49,604
-44.3%
14,4620.0%0.00%
Q3 2022$89,00014,4620.00%
Other shareholders
KIORA PHARMACEUTICALS INC shareholders Q3 2022
NameSharesValueWeighting ↓
XTX Topco Ltd 11,790$6,9440.00%
ALBION FINANCIAL GROUP /UT 6$40.00%
UBS Group AG 1,468$8340.00%
NewEdge Advisors, LLC 200$1140.00%
OSAIC HOLDINGS, INC. 36$200.00%
FMR LLC 2$10.00%
US BANCORP \DE\ 67$380.00%
WELLS FARGO & COMPANY/MN 113$640.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 37,211$21,9170.00%
View complete list of KIORA PHARMACEUTICALS INC shareholders